ArticleThe Lancet. Respiratory medicine2023

Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study.

Matan Yechezkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.